Skip to main content
AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
2.600
+0.070 (2.77%)
Apr 24, 2025, 4:00 PM EDT - Market closed

AbCellera Biologics Revenue by Segment
Period Ending Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Research Fees
4.77M 28.00 28.00 32.00 33.00 36.00 37.00 40.00
Licensing
281.77K 953.00 921.00 777.00 969.00 948.00 916.00 837.00
Research Fees Growth
14,448,445.45% -22.22% -24.32% -20.00% -15.38% 12.50% 23.33% 73.91%
Licensing Growth
28,978.22% 0.53% 0.55% -7.17% 39.22% 58.53% 44.48% 11.60%
Milestone Payments
- - 251.00 - 251.00 - - 901.00
Milestone Payments Growth
- - - - -72.11% - - -

Operating Metrics

Period Ending Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Partnered Program Starts
- - - - 404.00 392.00 374.00 356.00 339.00 342.00 319.00 291.00
Partnered Program Starts Growth
- - - - 19.17% 14.62% 17.24% 22.34% 29.89% 45.53% 47.00% 41.95%
Programs Under Contract
- - - - 203.00 182.00 177.00 177.00 174.00 164.00 164.00 158.00
Programs Under Contract Growth
- - - - 16.67% 10.98% 7.93% 12.03% 11.54% 5.81% 18.84% 32.77%
Number of Molecules in the Clinic
57.00 54.00 50.00 45.00 41.00 36.00 33.00 30.00
Number of Molecules in the Clinic Growth
39.02% 50.00% 51.52% 50.00% 51.85% 50.00% 50.00% 50.00%
Number of Discovery Partners
- - - - 46.00 42.00 41.00 41.00 40.00 38.00 38.00 36.00
Number of Discovery Partners Growth
- - - - 15.00% 10.53% 7.89% 13.89% 11.11% 8.57% 15.15% 24.14%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.